Blood Test Using 10 Biomarkers May Help Predict Chronic Disease Risk
Researchers developed a simplified metabolic health score using routine blood markers to identify people at greater risk of developing cardiometabolic disease.
Read MorePosted by CLP Edit Staff | Oct 30, 2026 | Cardiovascular, Clinical Chemistry, Diabetes & Metabolic Diseases |
Researchers developed a simplified metabolic health score using routine blood markers to identify people at greater risk of developing cardiometabolic disease.
Read MorePosted by CLP Edit Staff | Oct 28, 2026 | Lung Cancer |
The automated immunohistochemistry test helps pathologists identify malignant mesothelioma while preserving biopsy tissue for additional testing.
Read MorePosted by CLP Edit Staff | Oct 27, 2026 | Cancer, Lung Cancer, Molecular Diagnostics |
The test monitors circulating tumor DNA without requiring tumor tissue profiling, with clinical study findings showing detection of disease progression a median of 7.4 months before imaging.
Read MorePosted by CLP Edit Staff | Oct 26, 2026 | Breast, Digital Pathology |
In a study of 372 patients, the model closely matched results from a 70-gene genomic test and identified differences in long-term survival.
Read MorePosted by CLP Edit Staff | Oct 26, 2026 | Cancer, Company News, Molecular Diagnostics |
Abbott has launched a next-generation Oncodetect MRD test that uses whole-genome sequencing to track up to 5,000 patient-specific cancer variants, offering a 30-fold increase in detection sensitivity, according to the company.
Read More